Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)

PURPOSE: Although aromatase inhibitors (AIs) prolong survival in postmenopausal breast cancer (BC) patients, AI-associated arthralgia can lead to discontinuation. Obese patients have higher rates of AI arthralgia than non-obese patients, but treatment options are limited. Omega-3 fatty acid (O3-FA)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Autores principales: Shen, Sherry, Unger, Joseph M., Crew, Katherine D., Till, Cathee, Greenlee, Heather, Gralow, Julie, Dakhil, Shaker R., Minasian, Lori M., Wade, James L., Fisch, Michael J., Henry, N Lynn, Hershman, Dawn L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6681817/
https://ncbi.nlm.nih.gov/pubmed/30159789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4946-0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares